News Article

Via Christi St. Teresa Named One of the Nation’s 100 Top Hospitals

Via Christi St. Teresa Named One of the Nation’s 100 Top Hospitals

Via Christi St. Teresa was recognized as one of the nation’s 100 Top Hospitals® according to an independent quality analysis provided by Premier, Inc.

“At Via Christi St. Teresa, our focus is always on delivering high quality, patient-centered care to our community,” said Laurie Labarca, President of Via Christi St. Teresa. “We are extremely honored to be recognized as one of the nation’s 100 Top Hospitals.”

To create the 100 Top Hospitals list, an objective, quantitative analysis of publicly available data on 2,599 U.S. hospitals and health systems was conducted to identify the top hospitals in the United States. This year’s analysis compared the study’s top performing hospitals to a peer group of similar hospitals and found that the 100 Top Hospitals® delivered better outcomes while operating more efficiently. Compared to their peers, this year’s top performers achieved fewer inpatient deaths, complications and infections, as well as lower expenses and shorter lengths of stay.

Via Christi St. Teresa has earned multiple recognitions for its commitment to quality care. In the past year, it was selected as one of America's Best-in-State Hospitals 2025 by Newsweek and Statista and as a "High-Performing" hospital in the treatment of diabetes by U.S. News & World Report.

Recent Kansas News
Via Christi announces new leaders for its St. Teresa and Rehabilitation hospitals
News Articles

Via Christi announces new leaders for its St. Teresa and Rehabilitation hospitals

Via Christi has appointed Lori Tackett, MSN, RN, as the new President of Via Christi St. Teresa and Travis Francis as Administrator of Via Christi Rehabilitation Hospital.
Via Christi St. Francis performs first-in-Kansas procedure in clinical trial to treat severe aortic regurgitation
News Articles

Via Christi St. Francis performs first-in-Kansas procedure in clinical trial to treat severe aortic regurgitation

The Structural Heart Program at Via Christi St. Francis is the first site in Kansas to treat a patient in the JOURNEY IDE clinical trial evaluating the Edwards J-Valve Transfemoral (TF) System for the treatment of severe aortic regurgitation (AR).
Via Christi St. Francis performs first U.S. procedure in clinical trial to treat coronary artery disease
News Articles

Via Christi St. Francis performs first U.S. procedure in clinical trial to treat coronary artery disease

Via Christi has announced its participation in Abbott’s TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) Investigational Device Exemption (IDE) trial.